In 2018, Evan Hughes’ New York Times Magazine story “The Pain Hustlers” profiled the meteoric rise and fall of a pharmaceutical startup called Insys. Just a few years after its initial public offering made the company a “Wall Street darling,” the chief executives faced federal racketeering charges for giving kickbacks to doctors who prescribed their […]
